Beclomethasone is a steroid that prevents the release of substances in the body that cause inflammation.
Beclomethasone nasal (for the nose) is used to treat symptoms such as congestion, sneezing, and runny nose caused by seasonal or year-round allergies. The Beconase brand of this medication is also used to keep nasal polyps from coming back after surgery to remove them.
Beclomethasone may also be used for purposes not listed in this medication guide.
Submit your review
Beconase AQ, Qnasl
Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have:
severe or ongoing nosebleed;
sores in the nose that won't heal;
blurred vision, eye pain, or seeing halos around lights;
signs of a hormonal disorder--worsening tiredness or muscle weakness, anxiety, feeling irritable, feeling light-headed, nausea, vomiting, loss of appetite, diarrhea, weight loss, or weight gain (especially in your face or your upper back and torso); or
signs of infection--fever, chills, sores or white patches in or around your nose, flu symptoms, redness or swelling.
Common side effects may include:
discomfort or irritation inside your nose;
sneezing, runny or stuffy nose;
fever, sore throat;
headache, nausea; or
unpleasant taste or smell.
Adults and Children 12 Years of Age and Older:The usual dosage is 1 or 2 nasal inhalations (42 to 84 mcg) in each nostril twice a day (total dose, 168 to 336 mcg/day). Children 6 to 12 Years of Age: Patients should be started with 1 nasal inhalation in each nostril twice daily; patients not adequately responding to 168 mcg or those with more severe symptoms may use 336 mcg (2 inhalations in each nostril). Once adequate control is achieved, the dosage should be decreased to 84 mcg (1 spray in each nostril) twice daily. BECONASE AQ Nasal Spray is not recommended for children below 6 years of age. The maximum total daily dosage should not exceed 2 sprays in each nostril twice daily (336 mcg/day). In patients who respond to BECONASE AQ Nasal Spray, an improvement of the symptoms of seasonal or perennial rhinitis usually becomes apparent within a few days after the start of therapy with BECONASE AQ Nasal Spray. However, symptomatic relief may not occur in some patients for as long as 2 weeks. BECONASE AQ Nasal Spray should not be continued beyond 3 weeks in the absence of significant symptomatic improvement. The therapeutic effects of corticosteroids, unlike those of decongestants, are not immediate. This should be explained to the patient in advance in order to ensure cooperation and continuation of treatment with the prescribed dosage regimen. In the presence of excessive nasal mucous secretion or edema of the nasal mucosa, the drug may fail to reach the site of intended action. In such cases it is advisable to use a nasal vasoconstrictor during the first 2 to 3 days of therapy with BECONASE AQ Nasal Spray.